Position in AMGN
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$226,687
+$6,429 QoQ
Shares Held
626
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#2,777
of 3,151 holders
Holding Since
Sep 2024
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cross Staff Investments Inc holds $6,352,495 across 7 Drug Manufacturers - General names. AMGN ranks #7 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,300 | $2,758,689 | |
| 2 | JNJ |
Johnson & Johnson
|
5,477 | $1,390,993 | |
| 3 | MRK |
Merck & Co., Inc.
|
7,397 | $950,514 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
6,350 | $365,887 | |
| 5 | MIRA |
Mira Pharmaceuticals, Inc.
|
359,401 | $340,352 | |
| 6 | PFE |
Pfizer Inc
|
13,263 | $319,373 | |
| 7 | AMGN |
Amgen Inc
This page
|
626 | $226,687 |
All Filings in AMGN
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $226,687 | 626 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $220,258 | 626 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $204,896 | 626 | Shares | Sole | 2026-02-27 | |
| 2024-09-30 | $201,703 | 626 | Shares | Sole | 2024-10-23 | |
| No filing history on record for this holder in this stock. | ||||||